Research And Scholarly Activities

Home > Research & Media > Research And Scholarly Activities

RESEARCH AND SCHOLARLY ACTIVITIES

POSTER PRESENTATIONS

1. Caso R, Watson TJ, Eshetu T, Cerfolio R, Abbas A, Lazar JF, Margolis M, Khaitan PG. Comparing open, thoracoscopic, and robotic segmentectomy for stage I-IIIA non-small cell lung cancer: A National Cancer Database analysis. General Thoracic Surgical Club, March 2022.

2. Khaitan PGa, Holliday Ta, Carroll A, Hofstetter W, Corsini E, Zhou N, Desale S, Margolis M, Lazar JF, Henderson HR, Malouf S, Hamm M, Watson TJ. Can clinical complete response predict pathologic complete response following neoadjuvant chemoradiation for esophageal cancer? Digestive Disease Week. May 2021. aDual first authorship.

3. Khaitan PG, Holliday T, Carroll A, Lazar JF, Margolis M, Henderson HR, Malouf S, Hamm M, Watson TJ. Can clinical complete response predict pathologic complete response following neoadjuvant chemoradiation for esophageal cancer? General Thoracic Surgical Club. March 2020. Tuscon, AZ.

4. Tejiram S, Khaitan PG, Watson TJ, Shults C, Marshall MB. Cadaveric simulation in preparation for technical challenge: Complete robotic distal tracheal and left mainstem resection and reconstruction utilizing extracorporeal membrane oxygenation. American Association for Thoracic Surgery Focus on Thoracic Surgery. October 2017. Las Vegas, NV.

5. Ramchandani M, Kim MP, Gaur P, Chinnadurai P, Lumsden A. Cone-beam CT guided localization and video-assisted thoracoscopic resection of peripheral pulmonary nodules. 17th ISMICS Annual Meeting. Jun 2017. Rome, Italy.

6. Establishment and characterization of human midgut carcinoid cell lines: Establishing targets for therapy. Society of Surgical Oncology. March 2009. Phoenix, AZ.

7. Blockade of in vivo tumor growth of newly established human midgut carcinoid tumors by Src inhibition. Gastrointestinal Cancers Symposium: Science and Multidisciplinary Management of GI Malignancies. January 2009. San Francisco, CA.

8. Correlation of endoscopic tumor length with lymph node involvement and poor long-term survival in esophageal cancer patients. Gastrointestinal Cancers Symposium: Science and Multidisciplinary Management of GI Malignancies. January 2009. San Francisco, CA.

9. Targeted therapy in newly established human neuroendocrine cell lines: Understanding molecular pathways. American Association of Cancer Research Annual Meeting, April 2008. San Diego, CA.

10. Identification of activated signaling pathways in gastrointestinal neuroendocrine tumors. North American Neuroendocrine Tumor Symposium: New Horizons in NET Management. February 2008. Southampton Bermuda.

11. Characterization of molecular targets in newly established human neuroendocrine tumor cell lines. Gastrointestinal Cancers Symposium: Science and Multidisciplinary Management of GI Malignancies. January 2008. Orlando, FL.

12. Transcriptional analysis of cardiac hypertrophy using murine models and angiotensin-II as a direct stimulant of cardiac growth and inotropy. Medical Student Research Forum. August 2001. UT-Southwestern, Dallas, TX.

ORAL PRESENTATIONS

1. “Robotic esophagectomy trends and early surgical outcomes: The US experience.” 58th STS Meeting, Jan 2022. Virtual.

2. “Comparing Open, Thoracoscopic, and Robotic Segmentectomy for Stage I-IIIA Non-Small Cell Lung Cancer: A National Cancer Database Analysis”. 29th ESTS Meeting, June 2021. Virtual.

3. “A Clinical Nomogram Predicting Pathologic Lymph-Node Involvement in Esophageal Cancer Patients”. American Surgical Association, April 2010. Chicago, IL.

4. “Staging of Gastroesophageal Adenocarcinomas: A Comparison between Esophageal Staging, Gastric Staging, and a Novel Worldwide Esophageal Cancer Collaboration Staging System”. Southern Thoracic Surgical Association, November 2009. Marco Island, FL.

5. “Targeting Src kinase activity halts growth of midgut carcinoid tumors in a murine model”. American Association of Cancer Research Annual Meeting, April 2009. Denver, CO.

Research Funding

(Instructions: Please be certain to provide information that is accurate and unambiguous. Information may be compared with that available elsewhere, e.g. the NIH RePORTER and the Office of Sponsored Programs. Delete those that do not apply; add if multiple)

Agency:

HMSPG Institutional Grant

Title of Project:

Genetic and epigenetic analysis of esophageal adenocarcinoma specimens to explain tumor response to neoadjuvant therapy

Dates of Project Period:

2015-2016

Corresponding PI:

Puja Gaur

Total Direct Costs over all years of award:

$40,000

Total Indirect Costs over all years of award:

$0

Total Direct plus Indirect Costs over all years of award:

$40,000

Role on Project:

Principal Investigator

Description: Studied biological repair pathways in chemo-radio naïve esophageal adenocarcinoma surgical specimens in order to better understand why different tumors behave differently to chemoradiation.

Percent Effort:

100%

Agency:

HMH Dyer and Baucum Fellowship

Title of Project:

Short-term and long-term evaluation of hiatal hernia repair with and without mesh

Dates of Project Period:

2015-2016

Corresponding PI:

Puja Gaur

Total Direct Costs over all years of award:

$10,000

Total Indirect Costs over all years of award:

$0

Total Direct plus Indirect Costs over all years of award:

$10,000

Role on Project:

Principal Investigator

Description: Analyzed whether application of mesh to reinforce hiatal hernia results in more complications when compared to primary suture repair of hiatus.

Percent Effort:

100%

Percentile (if known):

100%

Agency:

NIH

Identifying Number:

T32

Title of Project:

Role of cancer stem cells in neuroendocrine tumors and tumor biology/angiogenesis of gastrointestinal malignancies

Dates of Project Period:

2007-2009

Corresponding PI:

Lee M. Ellis, MD

Description: As a NIH-T32 recipient, I conducted basic science research under the guidance of Dr. Lee Ellis to study cancer stem cells and angiogenic pathways in different gastrointestinal malignancies.

Percent Effort:

100%

Percentile (if known):

100%

Agency:

University of Texas Southwestern Medical School

Title of Project:

Cerebrospinal fluid and peripheral B cell repertoire analysis of two patients with primary progressive multiple sclerosis

Dates of Project Period:

2001

Corresponding PI:

Michael K. Racke, Ph.D.; Nancy L. Monson, Ph.D

Description: Participated in a large multi-institutional project on newly diagnosed multiple sclerosis patients and analyzed their B cells in CSF and peripheral blood to understand mutations.

Percent Effort:

100%

Percentile (if known):

100%

Agency:

University of Texas Southwestern Medical School

Title of Project:

Transcriptional analysis of cardiac hypertrophy using murine models and angiotensin-II as a direct stimulant of cardiac growth and inotropy

Dates of Project Period:

2000

Corresponding PI:

Ralph V. Shohet, MD

Description: Developed a mice model of cardiac hypertrophy by daily intra-peritoneal injections of AT-II and then analyzed cardiac response by studying RNA via Northern blots.